Cycloalkyl keto piperidine tachykinin receptor antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 211/00 (2006.01) C07D 405/00 (2006.01) C07D 409/00 (2006.01) C07D 411/00 (2006.01) C07D 413/00 (2006.01) C07D 417/00 (2006.01) C07D 419/00 (2006.01) C07D 421/00 (2006.01)

Patent

CA 2587195

The present invention is directed to certain piperidine compounds which are useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance P. The invention is also concerned with pharmaceutical formulations comprising these compounds as active ingredients and the use of the compounds and their formulations in the treatment of certain disorders, including emesis, urinary incontinence, depression, and anxiety.

La présente invention concerne des composés de pipéridine utiles comme antagonistes des récepteurs de la neurokinine 1 (NK-1) et comme inhibiteurs de la tachykinine, et notamment de la substance P. L'invention concerne également des préparations pharmaceutiques comprenant ces composés comme ingrédients actifs ainsi que l'utilisation de ces composés et de leurs préparations dans le traitement de certaines affections, telles que le vomissement, l'incontinence urinaire, la dépression et l'anxiété.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Cycloalkyl keto piperidine tachykinin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cycloalkyl keto piperidine tachykinin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cycloalkyl keto piperidine tachykinin receptor antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1790059

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.